Showing results (41-50 of 532) with videos related to

Sort By:
Pageof 54
Current Opinion in Hematology|May 27, 2009
Molecular signatures in acute myeloid leukemiaKrzysztof Mrózek, Michael D Radmacher, Clara D Bloomfield, et al.
Annals of Hematology|May 24, 2024
Blinatumomab-induced macrophage activating syndrome (MAS) in adult with B-cell acute lymphoblastic leukemia (B-ALL)Adam Braun, Salman Otoukesh, Jose Tinajero, et al.
British Journal of Haematology|May 10, 2007
Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise reviewClaudia D Baldus, Krzysztof Mrózek, Guido Marcucci, et al.
Current Hematologic Malignancy Reports|April 29, 2010
MicroRNA expression in acute myeloid leukemiaGuido Marcucci, Michael D Radmacher, Krzysztof Mrózek, et al.
Current Opinion in Hematology|January 22, 2013
Emerging immunotherapies in older adults with acute myeloid leukemiaSumithira Vasu, William Blum
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Novel therapies in AML: reason for hope or just hype?Karilyn Larkin, William Blum
Seminars in Thrombosis and Hemostasis|May 26, 2007
Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndromeWilliam Blum, Pierluigi Porcu
Current Opinion in Hematology|January 19, 2017
Making the most of hypomethylating agents in myelodysplastic syndromeGeetika Bhatt, William Blum
British Journal of Haematology|February 26, 2013
Low dose decitabine in very high risk relapsed or refractory acute myeloid leukaemia in children and young adultsChristine L Phillips, Stella M Davies, Richard McMasters, et al.
Journal of Clinical Pharmacology|April 16, 2005
Bioavailability of azacitidine subcutaneous versus intravenous in patients with the myelodysplastic syndromesGuido Marcucci, Lewis Silverman, Mark Eller, et al.
Pageof 54